- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 349085-82-1] GSK137647A
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-19995 |
| Brand: | MCE |
| CAS: | 349085-82-1 |
Overview
| MDL | MFCD02007969 |
|---|---|
| Molecular Weight | 305.39 |
| Molecular Formula | C16H19NO3S |
| SMILES | O=S(C1=CC=C(OC)C=C1)(NC2=C(C)C=C(C)C=C2C)=O |
1 Publications Citing Use of MCE
Summary
GSK137647A (GSK 137647) is a potent, selective free fatty acid receptor 4 ( FFA4 ) agonist with pEC 50 values of 6.3, 6.2, and 6.1 for human, mouse and rat FFA4, and pEC 50 values < 4.5 for all three species for FFA1, FFA2, and FFA3, respectively. GSK137647A has anti-inflammatory activity. GSK137647A induces insulin secretion and inhibits epithelial ion transport, GSK137647A is related to regulation of glucose homeostasis and anti-inflammatory response [1] [2] .
In Vitro
GSK137647A (GSK 137647) (50 µM) reduces the production of NO in macrophages without affecting cell viability
[1]
.
GSK137647A (GSK 137647) (30 µM; 12 hours) alleviates response to inflammatory stimuli in Caco-2 cells and induces secretion of IL-6
[1]
.
GSK137647A (GSK 137647) (10 µM) reduces the ion flow and affects the colonic epithelial ion transport in healthy
[1]
.
GSK137647A (GSK 137647) (50 µM) increases glucose stimulated insulin secretion
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Western Blot Analysis [1]
| Cell Line: | Caco-2 cells |
| Concentration: | 30 µM |
| Incubation Time: | 12 hours |
| Result: | Downregulated FFAR1, FFAR2, and FFAR4 as compared to control. |
Cell Viability Assay [1]
| Cell Line: | RAW264.7 macrophages |
| Concentration: | 10, 20 and 50 µM |
| Incubation Time: | 24 hours |
| Result: | Without affected cell viability. |
In Vivo
GSK137647A (GSK 137647) (1 mg/kg; i.p.; twice daily, for 7 days; C57BL/6 mice) alleviates colitis in TNBS- and DSS-treated mice
[1]
.
GSK137647A (GSK 137647) (1 mg/kg; i.p.; twice daily, for 7 days; C57BL/6 mice) restores intestinal permeability in vivo
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | Male C57BL/6 mice [1] |
| Dosage: | 1 mg/kg |
| Administration: | Intraperitoneal injection; twice daily, for 7 days |
| Result: | Had anti-inflammatory effect and reversed colonic injury induced by DSS. |
| Animal Model: | Male C57BL/6 mice [1] |
| Dosage: | 1 mg/kg |
| Administration: | Intraperitoneal injection; twice daily, for 7 days |
| Result: | Decreased the amount of FITC and alleviated intestinal epithelial barrier permeability. |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : ≥ 100 mg/mL ( 327.45 mM )
H 2 O : mg/mL (ultrasonic;warming) (Need ultrasonic and warming)
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 3.2745 mL | 16.3725 mL | 32.7450 mL |
| 5 mM | 0.6549 mL | 3.2745 mL | 6.5490 mL |
| 10 mM | 0.3275 mL | 1.6373 mL | 3.2745 mL |
-
1.
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (8.19 mM); Clear solution
References
- [1] Salaga M, et, al. Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice. Nutrients. 2021 Aug 6;13(8):2716.
- [2] Sparks SM, et, al. Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). Bioorg Med Chem Lett. 2014 Jul 15;24(14):3100-3.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.